The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the position of the FDA that you can't test a drug claiming it has an anti-aging effect will be of less relevance if some of the uh over-the-counter non-prescription medicines actually slow a in first in mice and then maybe also eventually in people I think that's an interesting political and legal question
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
in terms of the science we now need to figure out what is ananth doing and is Meine acting through tour or through some other Target as any new drug does it opens up um new possibilities for mechanistic exploration you can bet we're going to be looking at the Aging rate indicators at tissues from Meine treated and aanin treated mice
neither of these led to a change in our measurement of Maximum lifespan this test of percentage of live mice at the 90th percentile it's possible that at a higher maybe even a lower dose it might have done that we're going to need to go back and do a more complete dose response curves